Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.

NCT06971965 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT06971965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06971965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 2, 2025
Completion date
December 31, 2032
Enrollment
578 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

papillary thyroid carcinoma, thyroid cancer